This inventor holds 4 USPTO granted patents and 7 published patent applications. Top assignees: Lumiradx UK Ltd., Axim Biotechnologies, Inc., Sapphire Biotech, Inc.. Active years: 2023-2025.
Company Filing History:
2 out of 23 
1 out of 11 
1 out of 1 Years Active: 2023-2025
Title: The Innovations of Sergei Svarovsky
Introduction
Sergei Svarovsky is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of assays for hemoglobin A1c. With a total of 4 patents to his name, Svarovsky's work has advanced the understanding and measurement of this important biomarker.
Latest Patents
One of his latest patents is focused on a saturation binding ratiometric assay. This patent describes methods, devices, and reagents for performing ratiometric assays for hemoglobin A1c. The methods involve a direct ratio determination between Hb A1c and normalized total hemoglobin, utilizing a saturating amount of hemoglobin. This ensures that Hb A1c binds proportionately to a substrate. In some applications, the assay utilizes a proximity label system for signal generation and/or labeled magnetic beads. The methods can be configured as either homogeneous or heterogeneous assays.
Career Highlights
Throughout his career, Sergei Svarovsky has worked with various companies, including Lumiradx UK Ltd. and Axim Biotechnologies, Inc. His experience in these organizations has allowed him to collaborate on innovative projects that push the boundaries of current medical technologies.
Collaborations
Some of his notable coworkers include Victor Manneh and John Walter Huemoeller, II. Their collaborative efforts have contributed to the successful development of new technologies in the field.
Conclusion
Sergei Svarovsky's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field of medical diagnostics, particularly in the accurate measurement of hemoglobin A1c.